Аномалия Эбштейна. Клинические рекомендации 2024

Аномалия Эбштейна. Клинические рекомендации 2024

Тип статьи: Клинические рекомендации

Библиографическая ссылка: Детские болезни сердца и сосудов. 2025; 22 (2): 127-

Цитировать как: . Аномалия Эбштейна. Клинические рекомендации 2024. Детские болезни сердца и сосудов. 2025; 22 (2): 127-. DOI:

Скачать (Download)

Литература

Brown M.L., Dearani J.A., Danielson G.K., Cetta F., Connolly H.M., Warnes C.A. et al. Mayo Clinic Congenital Heart Center. The outcomes of operations for 539 patients with Ebstein anomaly. J. Thorac. Cardiovasc. Surg. 2008; 135 (5): 1120–1136, 1136.e1–7. DOI: 10.1016/j. jtcvs.2008.02.034
Бокерия Л.А., Шаталов К.В. Детская кардиохирургия. М.; 2016: 294–312.
Giamberti A., Chessa M. The tricuspid valve in congenital heart disease. Springer-Verlag Italia; 2014.
Бокерия Л.А., Подзолков В.П., Сабиров Б.Н. Аномалия Эбштейна. М.; 2005: 151–206.
Walsh E.P. Ebstein’s anomaly of the tricuspid valve: a Natural Laboratory for Re-Entrant Tachycardias. JACC Clin. Electrophysiol. 2018; 4 (10): 1271–1288. DOI: 10.1016/j.jacep.2018.05.024
Janson C.M., Shah M.J. Supraventricular tachycardia in adult congenital heart disease: mechanisms, diagnosis, and clinical aspects. Card. Electrophysiol Clin. 2017; 9 (2): 189–211. DOI: 10.1016/j.ccep.2017.02.005
Khairy P. Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know. Can. J. Cardiol. 2019; 35 (12): 1698–1707. DOI: 10.1016/j.cjca.2019.07.009
Mavroudis C., Dearani J.A. Atlas of adult congenital heart surgery. Springer Nature Switzerland AG; 2020.
Roten L., Lukac P., De Groot N., Nielsen J.C., Szili-Torok T., Jensen H.K. et al. Catheter ablation of arrhythmias in Ebstein’s anomaly: a multicenter study. J. Cardiovasc. Electrophysiol. 2011; 22 (12): 1391–1396. DOI: 10.1111/ j.1540-8167.2011.02161.x
Wackel P., Cannon B., Dearani J., Sessions K., Holst K., Johnson J., Cetta F. Arrhythmia after cone repair for Ebstein anomaly: the Mayo Clinic experience in 143 young patients. Congenit. Heart Dis. 2018; 13 (1): 26–30. DOI: 10.1111/chd.12566
Delhaas T., Sarvaas G.J., Rijlaarsdam M.E., Strengers J.L., Eveleigh R.M., Poulino S.E. et al. A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr. Cardiol. 2010; 31 (2): 229–233. DOI: 10.1007/s00246-009-9590-3
Raju V., Dearani J.A., Burkhart H.M., Grogan M., Phillips S.D., Ammash N. et al. Right ventricular unloading for heart failure related to Ebstein malformation. Ann. Thorac. Surg. 2014; 98 (1): 167–173; discussion 173–174. DOI: 10.1016/j.athoracsur.2014.03.009
Obioha-Ngwu O., Milliez P., Richardson A., Pittaro M., Josephson M.E. Ventricular tachycardia in Ebstein's Anomaly. Circulation. 2001; 104(18): E92–94. DOI: 10.1161/hc4301.098011
Shivapour J.K., Sherwin E.D., Alexander M.E., Cecchin F., Mah D.Y., Triedman J.K. et al. Tility of preoperative electrophysiologic studies in patients with Ebstein’s anomaly undergoing the Cone procedure. Heart Rhythm. 2014; 11 (2): 182–186. DOI: 10.1016/j.hrthm.2013. 10.045
Kubuš P., Vít P., Gebauer R.A., Materna O., Janoušek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ. Arrhythm. Electrophysiol. 2014; 7 (2): 218–223. DOI: 10.1161/CIRCEP.113.000930
McIntosh N., Chitayat D., Bardanis M., Fouron J.C. Ebstein anomaly: report of a familial occurrence and prenatal diagnosis. Am. J. Med. Genet. 1992; 42 (3): 307–309. DOI: 10.1002/ajmg.1320420309
De Lonlay-Debeney P., de Blois M.C., Bonnet D., Amiel J., Abadie V., Picq M. et al. Ebstein anomaly associated with rearrangements of chromosomal region 11q. Am. J. Med. Genet. 1998; 80 (2): 157–159. DOI: 10.1002/(sici)1096-8628(19981102)80:2<157::aid- ajmg12>3.0.co;2-u
Delhaas T., Sarvaas G.J., Rijlaarsdam M.E., Strengers J.L., Eveleigh R.M., Poulino S.E. et al. A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr. Cardiol. 2010; 31 (2): 229–233. DOI: 10.1007/s00246-009-9590-3
Raju V., Dearani J.A., Burkhart H.M., Grogan M., Phillips S.D., Ammash N. et al. Right ventricular unloading for heart failure related to Ebstein malformation. Ann. Thorac. Surg. 2014; 98 (1): 167–173; discussion 173–174. DOI: 10.1016/j.athoracsur.2014.03.009
Obioha-Ngwu O., Milliez P., Richardson A., Pittaro M., Josephson M.E. Ventricular tachycardia in Ebstein's Anomaly. Circulation. 2001; 104(18): E92–94. DOI: 10.1161/hc4301.098011
Shivapour J.K., Sherwin E.D., Alexander M.E., Cecchin F., Mah D.Y., Triedman J.K. et al. Tility of preoperative electrophysiologic studies in patients with Ebstein’s anomaly undergoing the Cone procedure. Heart Rhythm. 2014; 11 (2): 182–186. DOI: 10.1016/j.hrthm.2013. 10.045
Kubuš P., Vít P., Gebauer R.A., Materna O., Janoušek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ. Arrhythm. Electrophysiol. 2014; 7 (2): 218–223. DOI: 10.1161/CIRCEP.113.000930
McIntosh N., Chitayat D., Bardanis M., Fouron J.C. Ebstein anomaly: report of a familial occurrence and prenatal diagnosis. Am. J. Med. Genet. 1992; 42 (3): 307–309. DOI: 10.1002/ajmg.1320420309
De Lonlay-Debeney P., de Blois M.C., Bonnet D., Amiel J., Abadie V., Picq M. et al. Ebstein anomaly associated with rearrangements of chromosomal region 11q. Am. J. Med. Genet. 1998; 80 (2): 157–159. DOI: 10.1002/(sici)1096-8628(19981102)80:2<157::aid- ajmg12>3.0.co;2-u
Digilio M.C., Bernardini L., Lepri F., Giuffrida M.G., Guida V., Baban A. et al. Ebstein anomaly: genetic heterogeneity and association with microdeletions 1p36 and 8p23.1. Am. J. Med. Genet. A. 2011; 155A (9): 2196–2202. DOI: 10.1002/ajmg.a.34131
Harvey R.P. NK-2 homeobox genes and heart development. Develop. Biol. 1996; 178 (2): 203–216. DOI: 10.1006/dbio.1996.0212
Postma A.V., van Engelen K., van de Meerakker J. et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ. Cardiovasc. Genet. 2011; 4 (1): 43–50. DOI: 10.1161/CIRCGENETICS.110.957985
Пеняева Е.В. Генетические аспекты аномалии Эбштейна и связанных с ней заболеваний сердца. Вестник РАМН. 2021; 76 (1): 67–74.
Celermajer D.S., Cullen S., Sullivan I.D., Spiegelhalter D.J., Wyse R.K., Deanfield J.E. Outcome in neonates with Ebstein’s anomaly. J. Am. Coll. Cardiol. 1992; 19 (5): 1041–1046. DOI: 10.1016/0735-1097(92)90291-t
Бураковский В.И., Бокерия Л.А. (ред.) Сердечно-сосудистая хирургия: Руководство. М.; 1989: 471–512.
Lang D., Oberhoffer R., Cook A., Sharland G., Allan L., Fagg N., Anderson R.H. Pathologic spectrum of malformations of the tricuspid valve in prenatal and neonatal life. J. Am. Coll. Cardiol. 1991; 17 (5): 1161–1167. DOI: 10.1016/0735-1097(91)90848-4
Sharland G.K., Chita S.K., Allan L.D. Tricuspid valve dysplasia or displacement in intrauterine life. J. Am. Coll. Cardiol. 1991; 17 (4): 944–949. DOI: 10.1016/0735-1097(91)90877-c
Castaneda A.R., Jonas R.A., Mayer J.E., Hanley F.L. Ebstein’s anomaly. In: Cardiac surgery of the neonate and infant. 1994: 273–280.
Carpentier A., Chauvaud S., Macé L., Relland J., Mihaileanu S., Marino J.P. et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J. Thorac. Cardiovasc. Surg. 1988; 96 (1): 92–101.
Sano S., Fujii Y., Kasahara S., Kuroko Y., Tateishi A., Yoshizumi K., Arai S. Repair of Ebstein’s anomaly in neonates and small infants: impact of right ventricular exclusion and its indications. Eur. J. Cardiothorac. Surg. 2014; 45 (3): 549–555; discussion 555. DOI: 10.1093/ ejcts/ezt465
Mizuno M., Hoashi T., Sakaguchi H., Kagisaki K., Kitano M., Kurosaki K. et al. Application of cone reconstruction for neonatal Ebstein anomaly or tricuspid valve dysplasia. Ann. Thorac. Surg. 2016; 101 (5): 1811–1817. DOI: 10.1016/j.athoracsur.2015.11.029
Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M. et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a Report of the American College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019; 73 (12): e81–e192. DOI: 10.1016/j.jacc.2018.08.1029
Erratum in: J. Am. Coll. Cardiol. 2019; 73 (18): 2361–2362. DOI: 10.1016/j.jacc.2019.03.018
Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur. Heart J. 2021; 42 (6): 563–645. DOI: 10.1093/eurheartj/ehaa554
Бокерия Л.А., Бокерия О.Л., Сабиров Б.Н., Тетвадзе И.В., Александрова М.Л., Черногривов И.Е., Мурзагалиев М.У. Современный подход и результаты одномоментной коррекции аномалии Эбштейна и синдрома Вольфа–Паркинсона–Уайта. Грудная и сердечно- сосудистая хирургия. 2012; 54 (1): 4–11.
Caldeira D., David C., Costa J., Ferreira J.J., Pinto F.J. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Pharmacother. 2018; 4 (2): 111–118. DOI: 10.1093/ehjcvp/pvx028
Бокерия Л.А., Голухова Е.З., Ревишвили А.Ш., Левант А.Д., Дадашева М.А., Джитава Т.Г. и др. Дифференцированный подход к хирургическому лечению аномалии Эбштейна, сочетающейся с синдромом Вольфа–Паркинсона–Уайта. Грудная и сердечно- сосудистая хирургия. 2003; 2: 12–17.
Bockeria L.A., Golukhova E.Z., Revishvili A.Sh., Levant A.D., Dadasheva M.A., Dzhitava T.G. et al. A differentiated approach to surgical treatment of Ebstein’s anomaly combined with Wolf–Parkinson–White syndrome. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2003; 2: 12–17 (in Russ.).
Долгов В.В. (ред.) Клиническая лабораторная диагностика: Учебник. М.: ФГБОУ ДПО «РМАНПО»; 2016.
Brugada J., Katritsis D.G., Arbelo E., Arribas F., Bax J.J., Blomström-Lundqvist C. et al. ESC scientific document group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur. Heart J. 2020; 41 (5): 655–720. DOI: 10.1093/eurheartj/ehz467
Rodseth R.N., Biccard B.M., Le Manach Y., Sessler D.I., Lurati Buse G.A., Thabane L. et al. The prognostic value of pre-operative and post- operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro- B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J. Am. Coll. Cardiol. 2014; 63 (2): 170–180. DOI: 10.1016/j.jacc.2013.08.1630
Lopes L.M., Damiano A.P., Moreira G.N., Azevedo T.J., Nagamatsu C.T., Tavares G.M. et al. The role of echocardiography as an isolated method for indicating surgery in patients with congenital heart disease. Arq. Bras. Cardiol. 2005; 84 (5): 381–386. DOI: 10.1590/s0066- 782x2005000500006
Iturralde P., Nava S., Sálica G., Medeiros A., Márquez M.F., Colin L. et al. Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J. Cardiovasc. Electrophysiol. 2006; 17 (12): 1332–1336. DOI: 10.1111/j.1540-8167.2006.00617.x
Danielson G.K., Fuster V. Surgical repair of Ebstein’s anomaly. Ann. Surg. 1982; 196 (4): 499–504. DOI: 10.1097/00000658-198210000- 00014
Бокерия Л.А. Тахиаритмии. Диагностика и хирургическое лечение. Л.: Медицина; 1989: 73–121.
DeWitt E.S., Beausejour-Ladouceur V., Whitehill R., Radiofrequency ablation versus medical therapy for first episode of atrial tachycardia in adults with congenital heart disease. Heart Rhythm. 2016; 13: S449.
Park J.B., Lee S.P., Lee J.H., Yoon Y.E., Park E.A., Kim H.K. et al. Quantification of right ventricular volume and function using single-beat three-dimensional echocardiography: A validation study with cardiac magnetic resonance. J. Am. Soc. Echocardiogr. 2016; 29 (5): 392–401. DOI: 10.1016/j.echo.2016.01.010
Kumor M., Lipczyńska M., Biernacka E.K., Klisiewicz A., Wójcik A., Konka M. et al. Cardiac arrest and ventricular arrhythmia in adults with Ebstein anomaly and left ventricular non-compaction. J. Cardiol. 2018; 71 (5): 484–487. DOI: 10.1016/j.jjcc.2017.11.012
Chauvaud S.M., Brancaccio G., Carpentier A.F. Cardiac arrhythmia in patients undergoing surgical repair of Ebstein’s anomaly. Ann. Thorac. Surg. 2001; 71 (5): 1547–1552. DOI: 10.1016/s0003-4975(01)02464-x
Kirklin J.W., Barratt-Boyes B.G. Cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 4rd ed. N.Y.; 2013.
Negoi R.I., Ispas A.T., Ghiorghiu I., Filipoiu F., Negoi I., Hostiuc M.E. et al. Complex Ebstein’s malformation: defining preoperative cardiac anatomy and function. J. Cardiac. Surg. 2013; 28 (1): 70–81. DOI:10.1111/jocs.12032
Jentzer J.C., DeWald T.A., Hernandez A.F. Combination of loop diuretics with thiazide-type diuretics in heart failure. J. Am. Coll. Cardiol. 2010; 56 (19): 1527–1534. DOI: 10.1016/j.jacc.2010.06.034
Rydman R., Shiina Y., Diller G.P., Niwa K., Li W., Uemura H. et al. Major adverse events and atrial tachycardia in Ebstein’s anomaly predicted by cardiovascular magnetic resonance. Heart. 2018; 104 (1): 37–44. DOI: 10.1136/heartjnl-2017-311274
Ahmed S., Nanda N.C., Nekkanti R., Pacifico A.D. Transesophageal three-dimensional echocardiographic demonstration of Ebstein’s anomaly. Echocardiography. 2003; 20 (3): 305–307. DOI: 10.1046/j.1540-8175.2003.03034.x
Van Noord P.T., Scohy T.V., McGhie J., Bogers A.J. Three-dimensional transesophageal echocardiography in Ebstein’s anomaly. Interact. Cardiovasc. Thorac. Surg. 2010; 10 (5): 836–837. DOI: 10.1510/icvts.2009.229476
Филатов А.Г., Горячев В.А. Роль электрофизиологического исследования в выборе тактики лечения патологии аномалии Эбштейна в сочетании с дополнительным предсердно-желудочковым соединением. Анналы аритмологии. 2018; 15 (4): 220–224. DOI: 10.15275/ annaritmol.2018.4.4
Iturralde P., Nava S., Sálica G., Medeiros A., Márquez M.F., Colin L. et al. Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J. Cardiovasc. Electrophysiol. 2006; 17 (12): 1332–1336. DOI: 10.1111/j.1540-8167.2006.00617.x
Zhu D., Chung H.F., Dobson A.J., Pandeya N., Giles G.G., Bruinsma F. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet. Public. Health. 2019; 4 (11): e553–e564. DOI: 10.1016/S2468-2667(19)30155- 0
Diller G.P., Dimopoulos K., Okonko D., Li W., Babu-Narayan S.V., Broberg C.S. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005; 112 (6): 828–835. DOI: 10.1161/ CIRCULATIONAHA.104.529800
Siân Pincott E., Burch M. Indications for heart transplantation in congenital heart disease. Curr. Cardiol. Rev. 2011; 7 (2): 51–58. DOI: 10.2174/157340311797484240
Book W.M., Shaddy R.E. Medical therapy in adults with congenital heart disease. Heart Fail. Clin. 2014; 10 (1): 167–178. DOI: 10.1016/j.hfc.2013.09.006
Диагностика и лечение ХСН у детей и подростков. Методические рекомендации. Ассоциация детских кардиологов. М.; 2010.
Kantor P.F., Lougheed J., Dancea A., McGillion M., Barbosa N., Chan C. et al. Children’s Heart Failure Study Group. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can. J. Cardiol. 2013; 29 (12): 1535–1552. DOI: 10.1016/j.cjca.2013.08.008
Priori S.G., Blomström-Lundqvist C. 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur. Heart J. 2015; 36 (41): 2757–2759. DOI: 10.1093/eurheartj/ehv445
Budts W., Börjesson M., Chessa M., van Buuren F., Trigo Trindade P., Corrado D. et al. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription. Eur. Heart J. 2013; 34 (47): 3669–3674. DOI: 10.1093/eurheartj/eht433
Gheorghiade M., Patel K., Filippatos G., Anker S.D., van Veldhuisen D.J., Cleland J.G. et al. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur. J. Heart Fail. 2013; 15 (5): 551–559. DOI: 10.1093/eurjhf/hft010
Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003; 289 (7): 871–878. DOI: 10.1001/jama.289.7.871
Bosnic Z. et al. Pathophysiological complexity of amiodarone-induced hypothyroidism (AIH) in patient with congenital heart disease – Ebstein anomaly: a case report. 2021. DOI: 10.21203/rs.3.rs-304220/v1
Hernández-Madrid A., Paul T., Abrams D., Aziz P.F., Blom N.A., Chen J. et al. ESC Scientific Document Group. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018; 20 (11): 1719–1753. DOI: 10.1093/europace/eux380
Beaufort-Krol G.C., Dijkstra S.S., Bink-Boelkens M.T. Natural history of ventricular premature contractions in children with a structurally normal heart: does origin matter? Europace. 2008; 10 (8): 998–1003. DOI: 10.1093/europace/eun121
Wang S., Zhu W., Hamilton R.M., Kirsh J.A., Stephenson E.A., Gross G.J. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm. 2010; 7 (12): 1725–1731. DOI: 10.1016/j.hrthm.2010.07.037
Collins K.K., Schaffer M.S., Liberman L., Saarel E., Knecht M., Tanel R.E. et al. Pediatric and Congenital Electrophysiology Society. Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. J. Cardiovasc. Electrophysiol. 2013; 24 (6): 640–648. DOI: 10.1111/jce.12105
Pappone C., Vicedomini G., Manguso F., Baldi M., Pappone A., Petretta A. et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. 2012; 125 (5): 661–668. DOI: 10.1161/CIRCULATIONAHA.111.065722
Renda G., Ricci F., Giugliano R.P., De Caterina R. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease. J. Am. Coll. Cardiol. 2017; 69 (11): 1363–1371. DOI: 10.1016/j.jacc.2016.12.038
Roldán V., Marín F., Manzano-Fernández S., Gallego P., Vílchez J.A., Valdés M. et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J. Am. Coll. Cardiol. 2013; 62(23): 2199–2204. DOI: 10.1016/j.jacc.2013.08.1623
Khairy P., Van Hare G.F., Balaji S., Berul C.I., Cecchin F., Cohen M.I. et al. PACES/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014; 11 (10): e102–165. DOI: 10.1016/j.hrthm.2014.05.009
Ahmed H., VanderPluym C. Medical management of pediatric heart failure. Cardiovasc. Diagn. Ther. 2021; 11 (1): 323–335. DOI: 10.21037/cdt-20-358
Heidbuchel H., Verhamme P., Alings M., Antz M., Diener H.C., Hacke W. et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015; 17 (10): 1467–1507. DOI: 10.1093/europace/euv309
Giglia T.M., Massicotte M.P., Tweddell J.S., Barst R.J., Bauman M., Erickson C.C. et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013; 128 (24): 2622–2703. DOI: 10.1161/01.cir.0000436140.77832.7a
Jensen A.S., Idorn L., Nørager B., Vejlstrup N., Sondergaard L. Anticoagulation in adults with congenital heart disease: the who, the when and the how? Heart. 2015; 101 (6): 424–429. DOI: 10.1136/heartjnl-2014-305576
Waldmann V., Laredo M., Abadir S., Mondésert B., Khairy P. Atrial fibrillation in adults with congenital heart disease. Int. J. Cardiol. 2019; 287: 148–154. DOI: 10.1016/j.ijcard.2019.01.079
Olesen J.B., Lip G.Y., Hansen M.L., Hansen P.R., Tolstrup J.S., Lindhardsen J. et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011; 342: d124. DOI: 10.1136/bmj.d124
Di Russo G.B., Gaynor J.W. Ebstein’s anomaly: indications for repair and surgical technique. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 1999; 2: 35–50. DOI: 10.1016/s1092-9126(99)70004-9

2024 Clinical practice guidelines for Ebstein’s anomaly

Authors:

Company:

Section: Clinical Guidelines

Электронная подписка

Для получения доступа к тексту статей журнала воспользуйтесь услугой «Электронная подписка»:

Оформить подписку Подробнее об электронной подписке

Главный редактор

Шаталов Константин Валентинович

доктор медицинских наук, профессор

Аномалия Эбштейна. Клинические рекомендации 2024

Электронная подписка

Главный редактор

Сортировать по